Sustained remission of multicentric Castleman disease in children treated with tocilizumab, an anti-interleukin-6 receptor antibody. [electronic resource]
Producer: 20121217Description: 1623-6 p. digitalISSN:- 1538-8514
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Castleman Disease -- diagnosis
- Child
- Female
- Humans
- Male
- Receptors, Interleukin-6 -- antagonists & inhibitors
- Remission Induction
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.